306 related articles for article (PubMed ID: 31861590)
21. Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma.
Murakami A; Wang L; Kalhorn S; Schraml P; Rathmell WK; Tan AC; Nemenoff R; Stenmark K; Jiang BH; Reyland ME; Heasley L; Hu CJ
Oncogenesis; 2017 Jan; 6(1):e287. PubMed ID: 28092369
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.
Sarnowska E; Szymanski M; Rusetska N; Ligaj M; Jancewicz I; Cwiek P; Skrodzka M; Leszczynski M; Szarkowska J; Chrzan A; Stachowiak M; Steciuk J; Maassen A; Galek L; Demkow T; Siedlecki JA; Sarnowski TJ
Am J Cancer Res; 2017; 7(11):2275-2289. PubMed ID: 29218250
[TBL] [Abstract][Full Text] [Related]
23. BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.
Eckel-Passow JE; Serie DJ; Cheville JC; Ho TH; Kapur P; Brugarolas J; Thompson RH; Leibovich BC; Kwon ED; Joseph RW; Parker AS
BMC Urol; 2017 Mar; 17(1):19. PubMed ID: 28327121
[TBL] [Abstract][Full Text] [Related]
24. Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
Beuselinck B; Verbiest A; Couchy G; Job S; de Reynies A; Meiller C; Albersen M; Verkarre V; Lerut E; Méjean A; Patard JJ; Laguerre B; Rioux-Leclercq N; Schöffski P; Oudard S; Zucman-Rossi J
Acta Oncol; 2018 Apr; 57(4):498-508. PubMed ID: 29095068
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.
Huang J; Cai W; Cai B; Kong W; Zhai W; Zhang J; Chen Y; Chen S; Bai Y; Huang Y; Xue W
Front Oncol; 2021; 11():697219. PubMed ID: 34568025
[TBL] [Abstract][Full Text] [Related]
26. Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
Carlo MI; Manley B; Patil S; Woo KM; Coskey DT; Redzematovic A; Arcila M; Ladanyi M; Lee W; Chen YB; Lee CH; Feldman DR; Hakimi AA; Motzer RJ; Hsieh JJ; Voss MH
Kidney Cancer; 2017 Jul; 1(1):49-56. PubMed ID: 30334004
[No Abstract] [Full Text] [Related]
27. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Varela I; Tarpey P; Raine K; Huang D; Ong CK; Stephens P; Davies H; Jones D; Lin ML; Teague J; Bignell G; Butler A; Cho J; Dalgliesh GL; Galappaththige D; Greenman C; Hardy C; Jia M; Latimer C; Lau KW; Marshall J; McLaren S; Menzies A; Mudie L; Stebbings L; Largaespada DA; Wessels LF; Richard S; Kahnoski RJ; Anema J; Tuveson DA; Perez-Mancera PA; Mustonen V; Fischer A; Adams DJ; Rust A; Chan-on W; Subimerb C; Dykema K; Furge K; Campbell PJ; Teh BT; Stratton MR; Futreal PA
Nature; 2011 Jan; 469(7331):539-42. PubMed ID: 21248752
[TBL] [Abstract][Full Text] [Related]
28. The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma.
Kim JY; Lee SH; Moon KC; Kwak C; Kim HH; Keam B; Kim TM; Heo DS
J Urol; 2015 Oct; 194(4):1112-9. PubMed ID: 25997916
[TBL] [Abstract][Full Text] [Related]
29.
Leung JY; Kim WY
Cancer Discov; 2017 Aug; 7(8):802-804. PubMed ID: 28765116
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation in RCC: opportunities for therapeutic intervention?
Larkin J; Goh XY; Vetter M; Pickering L; Swanton C
Nat Rev Urol; 2012 Jan; 9(3):147-55. PubMed ID: 22249190
[TBL] [Abstract][Full Text] [Related]
31. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective.
Shenoy N; Pagliaro L
Ann Oncol; 2016 Sep; 27(9):1685-95. PubMed ID: 27329246
[TBL] [Abstract][Full Text] [Related]
32.
Santos M; Lanillos J; Caleiras E; Valdivia C; Roldan-Romero JM; Laínez N; Puente J; Beuselinck B; Oudard S; Zucman-Rossi J; Navarro P; Robledo M; Castellano D; de Velasco G; García-Donas J; Rodriguez-Antona C
Am J Cancer Res; 2023; 13(5):2116-2125. PubMed ID: 37293154
[TBL] [Abstract][Full Text] [Related]
33. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?
Batavia AA; Schraml P; Moch H
Histopathology; 2019 Jan; 74(1):60-67. PubMed ID: 30565303
[TBL] [Abstract][Full Text] [Related]
34. Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma.
Xu Z; Jiang W; Liu L; Qiu Y; Wang J; Dai S; Guo J; Xu J
Cancer Immunol Immunother; 2024 Apr; 73(5):95. PubMed ID: 38607586
[TBL] [Abstract][Full Text] [Related]
35. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
36. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
[TBL] [Abstract][Full Text] [Related]
37. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract][Full Text] [Related]
38. Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma.
He D; Ma T; Yi N; Zhang S; Ding G
Biotechnol Genet Eng Rev; 2023 Apr; ():1-15. PubMed ID: 37079762
[TBL] [Abstract][Full Text] [Related]
39. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
[TBL] [Abstract][Full Text] [Related]
40. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
